Diplomat Pharmacy (DPLO) Tops Q4 EPS by 2c; Issues Strong FY15 EPS Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. NDAQ
9. TSCO
10. BE

Go back to Diplomat Pharmacy (DPLO) Tops Q4 EPS by 2c; Issues Strong FY15 EPS Outlook

Biolase (BIOL) Names New CFO

March 2, 2015 8:56 AM EST

Biolase (NASDAQ: BIOL) announced that it has hired veteran financial executive David C. Dreyer as its Chief Financial Officer. He will report to BIOLASE President and CEO Jeffrey M. Nugent and join the Company, effective March 9. Mr. Dreyer replaces Frederick D. Furry, who resigned January 31 to pursue other opportunities.

Mr. Dreyer has extensive experience as a Chief Financial Officer for a number of publicly-owned medical device, medical staffing and pharmaceutical companies. He also has hands-on experience in healthcare services, biotech/pharmaceutical and medical device research, manufacturing and marketing.

Most recently, from 2010 to... More